Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
Incorporate the latest research findings into your clinical practice with the #1 annually updated guide to internal medicine. Download the FREE app and view selected topics (Approximately 10% of the content is viewable in the free app and tapping on the locked topic will launch the in-app purchase screen). HERE IS WHY CMDT IS THE ULTIMATE CLINICAL COMPANION: - Medical advances up to time of annual publication - Detailed presentation of primary care topics, including gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women’s health, preventive medicine, and palliative care - Concise format, facilitating efficient use in any practice setting - More than 1000 diseases and disorders - Annual update on HIV/AIDS and other newly emerging infections. - Specific disease prevention information - Easy access to medication dosages, with trade names indexed and costs updated in each edition - Recent references, with unique identifiers (PubMed, PMID numbers) for rapid downloading of article abstracts and, in some instances, full-text reference articles NEW TO THIS EDITION OF CMDT : - Substantial revision of acute and chronic (cancer and noncancer) pain management and benefits and risks of opioid use - New chapter on Lesbian, Gay, Bisexual, & Transgender Health - New recommendations for initial empiric antibiotic treatment for hospital-acquired and ventilator-associated pneumonia - New discussion of physician-assisted death - New Table outlining criteria to rule out pulmonary embolism - 2016 CHEST Guideline and Expert Panel Report detailing anticoagulation treatment recommendations in patients with cancer and noncancer diagnoses - New categorization of pressure injuries (formerly pressure ulcers) - New treatment recommendations from American College of Cardiology/American Heart Association and the European Society of Cardiology for patients who have heart failure with reduced ejection fraction - Rewritten section on occlusive cerebrovascular disease - Rewritten section on shock - New information on treatments for chronic lymphocytic leukemia and Hodgkin lymphoma - Updated treatment options for plasma cell myeloma (formerly multiple myeloma) - New FDA-approved medication for Clostridium difficile infection - Updated treatment options for hepatitis C infection - New FDA-approved medications for ulcerative colitis and Crohn disease - New pharmacologic treatment for hormone receptor–positive breast cancer - Rewritten section on attention-deficit/hyperactivity disorder - New section on autism spectrum disorder - Extensive revision of Endocrine Disorders chapter - Updated recommendations for preexposure prophylaxis of HIV infection - Substantial revision of the Viral & Rickettsial Infections chapter New antiemetic combination medication for chemotherapy-induced nausea - New therapy options for castration-resistant prostate cancer - New FDA-approved medication for bladder cancer About the Authors: Maxine A. Papadakis, MD Professor of Medicine, Emeritus Department of Medicine University of California, San Francisco Stephen J. McPhee, M.D. Professor of Medicine, Emeritus Division of General Internal Medicine Department of Medicine University of California, San Francisco
